Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Duell et al.
J Immunother 2019; 42:180-188.
Duell et al.
J Immunother 2019; 42:180-188.
Kluge et al.
AACR 2019 - AFM24
Marin et al.
AACR 2019 - AFM13
Bartlett et al.
ASH 2018 - AFM13-103
Wingert et al.
ASH 2018 - Macrophages
Ross et al.
ASH 2018 - AFM26
Sawas et al.
ASH 2018 - AFM13-102
Salogub et al.
ASH 2018 - AFM11
Bartlett et al.
23rd Congress of EHA – AFM13
Pahl et al.
Cancer Immunol Res 2018; 6:517-527.